OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
April 01, 2013
First gene therapy and plant-based expression vector products approved in 2012.
The author outlines the need for custom-cell products.
Manufacturing Best Practices
Benchmarking can be a useful tool to improve manufacturing practices.
Perspectives on Outsourcing
An innovative approach to capacity management.
Have FDA initiatives improved manufacturing quality?
Latin America's diverse growing market seeks regulatory harmonization.
The authors propose a roadmap for analytical lifecycle development.
Opioid abuse generates calls for efforts to curb distribution.
Sound policies are needed to govern the substitution of interchangeable biologics.
Burrill on Biotech
Early-stage companies are finding alternatives to venture capital.
Boot Camp Tech Guide
Applications of ZFN technology in biopharmaceutical cell-line engineering.
Ontario-area scientists discuss approaches to development of stem-cell therapies.
EU authorities are stepping up their efforts to incorporate QbD principles.
The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred-tank bioreactor.
The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.
Click the title above to open the BioPharm International April 2013 issue in an interactive PDF format.